Last reviewed: June 5, 2026

Last updated: June 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 receptor agonists have transformed weight loss treatment, with clinical trials showing average weight reductions of 15 to 22 percent over 68 weeks. However, eligibility depends on your health history, current medications, and specific medical conditions. PlexusDx works with qualified candidates to deliver personalized compounded GLP-1 therapy starting at $149 per month.

What Medical Conditions Disqualify You From GLP-1 Treatment

Certain medical histories prevent safe GLP-1 use. A personal or family history of medullary thyroid carcinoma (MTC) is an absolute contraindication because GLP-1 drugs may stimulate C-cell growth in the thyroid. Similarly, individuals with a family history of multiple endocrine neoplasia syndrome type 2 (MEN2) should not use these medications due to inherited thyroid cancer risk.

Severe pancreatitis history and diabetic retinopathy requiring treatment also raise safety concerns. Patients with a prior allergic reaction to semaglutide, tirzepatide, or any component of the formulation cannot safely take GLP-1 therapy. Additionally, those with active gallbladder disease or a history of gallstone pancreatitis may need medical clearance before starting treatment.

Pregnancy and breastfeeding are contraindications because animal studies show potential effects on fetal development. Women of childbearing age should use reliable contraception during GLP-1 treatment and for at least two months after stopping. Anyone with untreated thyroid nodules should have them evaluated before beginning therapy.

Health Requirements for GLP-1 Candidacy

PlexusDx evaluates cardiovascular stability and kidney function through your health history and existing lab work. Patients with a body mass index (BMI) of 30 or higher, or BMI of 27 or higher with weight-related health conditions like hypertension or type 2 diabetes, generally qualify for GLP-1 treatment. A stable resting heart rate and normal kidney markers support safe medication use.

Blood pressure control matters because GLP-1 drugs can cause dehydration and affect fluid balance. Patients taking blood pressure medications should have readings documented and stable before starting therapy. Liver function must be adequate, as the kidneys and liver process these medications, and significant organ impairment requires careful medical consideration.

Age eligibility typically includes adults 18 and older, though clinical data in patients over 75 remains limited. Adolescents 12 and older with obesity may qualify in specific cases, but pediatric use requires specialized evaluation. Overall health stability and the absence of acute illness strengthen candidacy for PlexusDx treatment programs.

Medication Interactions and Current Prescriptions That Matter

GLP-1 drugs interact significantly with insulin and sulfonylurea diabetes medications, which increase hypoglycemia risk when combined. Patients taking insulin or medications like glipizide may need dose adjustments once GLP-1 therapy begins, so close medical monitoring is essential. Thyroid medications and certain gastroparesis treatments can also interact, requiring dose timing adjustments or alternative approaches.

Oral contraceptives may have reduced effectiveness during rapid weight loss, as nutrient absorption changes and medication clearance increases. Women using birth control should discuss backup contraception strategies with their provider. Other medications including warfarin, statins, and antidepressants typically remain safe but may require monitoring as metabolism shifts during weight loss.

PlexusDx reviewers examine your complete medication list during the qualification process to identify interactions early. Patients on dialysis or with advanced chronic kidney disease need specialized assessment. Alcohol use and substance history inform dosing decisions, as dehydration risk increases with certain combinations.

Getting Started: PlexusDx Qualification and Personalization

PlexusDx requires a detailed health history and consultation before dispensing compounded semaglutide injection or any GLP-1 medication. The process evaluates weight, height, BMI, blood pressure, heart rate, current medications, and medical history. Recent lab work strengthens applications, though PlexusDx can work with patients who need initial testing at an outside facility.

Once qualified, PlexusDx patients can add the Precision Peptide Genetic Test ($99 after first month) to identify how genetic variants in pathways like GLP1R, GIPR, FTO, and MC4R affect individual weight loss response. This peptide-pathway genetic testing maps 14 metabolic pathways and 49 peptide mechanisms, enabling truly personalized dosing and medication selection. Semaglutide injections start at $149 monthly across all commitment tiers, with no your dose may need to go up - your price won't increases.

Patients in all 50 states qualify without insurance requirements or membership fees. HSA and FSA accounts cover compounded GLP-1 therapy from PlexusDx licensed 503A pharmacies. The entire process—from qualification to first shipment—typically takes one to two weeks, with ongoing telehealth support for dose adjustments and monitoring.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I take GLP-1 if I have type 2 diabetes?

Yes, GLP-1 medications are approved for type 2 diabetes and weight loss together. However, if you take insulin or sulfonylurea medications, your doses may need adjustment once GLP-1 therapy starts to prevent low blood sugar. PlexusDx reviews your complete diabetes management plan before qualification.

What if I have a history of thyroid problems?

A personal or family history of medullary thyroid carcinoma or MEN2 syndrome disqualifies you from GLP-1 treatment entirely. Benign thyroid nodules may be safe with medical clearance and monitoring. Hypothyroidism or Hashimoto's disease on stable thyroid replacement therapy typically do not prevent GLP-1 use, but your endocrinologist should approve the plan.

How much does GLP-1 treatment cost at PlexusDx?

Compounded semaglutide injection starts at $149 per month with no your dose may need to go up - your price won't increases. Oral semaglutide begins at $249 monthly, and tirzepatide options range from $249 to $289 monthly. PlexusDx accepts HSA and FSA funds and serves all 50 states without membership fees or insurance requirements.

What side effects should disqualify me from GLP-1?

Prior severe allergic reactions to GLP-1 drugs are disqualifying. Nausea, constipation, and appetite loss are expected and manageable. However, severe pancreatitis, uncontrolled gallbladder disease, or signs of thyroid tumors require medical evaluation before starting. PlexusDx screens for these risks during the qualification process.

How does the Precision Peptide Genetic Test improve my GLP-1 results?

PlexusDx's genetic test ($99 add-on) identifies your unique variants in GLP1R, GIPR, FTO, MC4R, and 45 other peptide genes across 14 metabolic pathways. This peptide-pathway analysis reveals how your body responds to GLP-1 therapy and informs whether semaglutide, tirzepatide, or dual-compound options suit you best. Personalized dosing based on genetics improves weight loss outcomes and side effect tolerability.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves